CHAI is pleased to share news today from MedAccess of measures to increase access to a patient-friendly preventative therapy for tuberculosis (TB). The volume guarantee agreement between MedAccess and Macleods Pharmaceuticals, in partnership with CHAI and...
Our monthly check-in with staff from around the world. Learn more about the people who work at CHAI. Please tell us a bit about your background and what brought you to CHAI. I grew up in France and studied veterinary medicine there. I have always been fascinated by...
TB program point-of-care testing was leveraged for HIV viral load and early infant diagnosis testing. Many national testing and treatment programs have traditionally been “vertical” in nature – focused on one disease alone – and have relied on processing tests in...
We were shocked and saddened to learn today that CHAI’s Board Chair, Dr. Tachi Yamada, has passed away. Tachi has been a driving force in global health for decades and his loss will be felt around the world. As a physician, professor, mentor, and leader of large and...
In 2011, the HPTN 052 trial demonstrated that people living with HIV who initiated treatment earlier – also referred to as early access to antiretroviral therapy (ART) for all – were less likely to transmit the virus to partners. Adoption of this approach meant that...
Hepatitis B (HBV) is an incurable liver infection that can lead to severe health consequences including liver failure and liver cancer. It is a silent killer – most people do not experience any symptoms when they get infected and children in particular are less able...
Hepatitis C (HCV) affects more than 58 million people worldwide, and a significant number of people with the disease will progress to chronic disease, liver cancer, and death. Although HCV is curable in more than 95 percent of patients with direct-acting antivirals...
Unitaid and the Clinton Health Access Initiative, Inc. (CHAI) announce pricing agreement with pharmaceutical company Hetero Labs LTD to make available generic version of best-in-class second-line therapy for people living with HIV. July 26, 2021 – Unitaid and CHAI...
A full list of sessions that CHAI is participating in at the Internationl AIDS Society conference. Presentation links will be updated when recordings are available, so check back regularly. Satelitte Sessions Ending cryptococcal meningitis deaths by 2030: Critical but...
CHAI presents cost-effectiveness modeling framework at IAS 2021 to understand the role of multipurpose prevention technologies in HIV prevention and family planning. Full lineup of CHAI IAS sessions here. By the age of 18, a woman in Zimbabwe is likely to be sexually...
